← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2021Last known activity
Mar 2, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 2 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (3)
- NCT05179733CollaboratorPhase 3Mar 2, 2022
- NCT05180851Lead sponsorEarly Phase 1Nov 30, 2021
- NCT05180851Overall official - principal investigatorEarly Phase 1Nov 30, 2021
Details
- Last known activity
- Mar 2, 2022